The NanoGAS™ series has been approved as an officially recommended product by the Japanese Society of Preemptive Clinical Medicine.
Synbiosis’ proprietary NanoGAS™ series, which supports our group’s transplantation bacteriological solutions, has been approved as an officially recommended product by the Japanese Society of Preemptive Clinical Medicine.
The transplanted bacteria solution used in our research group is Ultra Fine Bubble (NanoGAS™) water, which contains invisible microscopic bubbles.
By utilizing the properties of Ultra Fine Bubble, we expect to effectively transplant intestinal bacteria of other people’s origin, which were originally considered to be blocked by autoimmune functions such as IgA (immunoglobulin A) and could not successfully take up residence.
Click here to learn more about the three properties and functions of the patent-pending Ultra Fine Bubble.
【特許出願中】UFB(NanoGAS™)水を使用した移植菌液We are pleased to announce that the NanoGAS™ series from Symbiosis, Inc. is now available for purchase as samples in small lots for a fee.
We have received requests for samples from a wide variety of companies and have responded to each request individually, but now we are pleased to announce that corporate customers can try our products.
Please see below for more details. Thank you for your continued support of the NanoGAS™ series.
NanoGAS™有償サンプル（法人様のみ）その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports
April 03, 2024
【Event】 Dr. Shirotani will speak at the 7th Annual Conference of the Japanese Society of Preemptive Clinical Medicine
Dr. Masahiko Shirotani, Executive Director of the Luke’s Ashiya Clinic, will deliver a special lecture at the 7th Annual Conference of the Japanese Society of Preemptive Medicine to be held on June 22 (Sat.) and 23 (Sun.), 2024. Dr. Zen Tanaka, President of Tanaka Clinic, Nizenkai Medical Corporation, will be the chairperson. Lecture Contents Special […]
March 04, 2024
〈Registration Start〉8th Annual Conference
We are pleased to announce that the 8th Annual Conference will be held again this year. (Venue and online)Anyone is welcome to attend, not only healthcare professionals, but also the general public, students, etc. Date and Time Sunday, September 22, 2024Start 11:00 am (Registration 10:30 am) – Closing at 5:00 pm *General Meeting: Held before […]
February 04, 2024
Interview with Goro Tsukamoto at the 7th Annual Meeting
‘Gut Flora Transplantation Clinical Study Group of Experts〜Aiming for easier access to treatment, we are challenging research and development.Pharmacist, Doctor of Engineering Goro Tsukamoto: Former Director and General Manager of Drug Discovery Research Institute, Bell Boss, Former Visiting Professor, University of Pittsburgh, USA, Former Professor, Nagaoka University of Technology The world’s first migraine drug, invented […]
